Literature DB >> 18388191

Identification of key amino acid residues in a thyrotropin receptor monoclonal antibody epitope provides insight into its inverse agonist and antagonist properties.

Chun-Rong Chen1, Sandra M McLachlan, Basil Rapoport.   

Abstract

CS-17 is a murine monoclonal antibody to the human TSH receptor (TSHR) with both inverse agonist and antagonist properties. Thus, in the absence of ligand, CS-17 reduces constitutive TSHR cAMP generation and also competes for TSH binding to the receptor. The present data indicate that for both of these functions, the monovalent CS-17 Fab (50 kDa) behaves identically to the intact, divalent IgG molecule (150 kDa). The surprising observation that CS-17 competes for TSH binding to the human but not porcine TSHR enabled identification of a number of amino acids in its epitope. Replacement of only three human TSHR residues (Y195, Q235, and S243) with the homologous porcine TSHR residues totally abolishes CS-17 binding as detected by flow cytometry. TSH binding is unaffected. Of these residues, Y195 is most important, with Q235 and S243 contributing to CS-17 binding to a much lesser degree. The functional effects of CS-17 IgG and Fab on constitutive cAMP generation by porcinized human TSHR confirm the CS-17 binding data. The location of TSHR amino acid residues Y195, Q235, and S243 deduced from the crystal structure of the FSH receptor leucine-rich domain provides valuable insight into the CS-17 and TSH binding sites. Whereas hormone ligands bind primarily to the concave surface of the leucine-rich domains, a major portion of the CS-17 epitope lies on the opposite convex surface with a minor component in close proximity to known TSH binding residues.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18388191      PMCID: PMC2453077          DOI: 10.1210/en.2008-0207

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  36 in total

1.  Model of glycoprotein hormone receptor ligand binding and signaling.

Authors:  William R Moyle; Yongna Xing; Win Lin; Donghui Cao; Rebecca V Myers; John E Kerrigan; Michael P Bernard
Journal:  J Biol Chem       Date:  2004-08-09       Impact factor: 5.157

2.  Dissecting linear and conformational epitopes on the native thyrotropin receptor.

Authors:  Takao Ando; Rauf Latif; Samira Daniel; Katsumi Eguchi; Terry F Davies
Journal:  Endocrinology       Date:  2004-08-05       Impact factor: 4.736

Review 3.  Antibody-antigen complexes.

Authors:  D R Davies; E A Padlan; S Sheriff
Journal:  Annu Rev Biochem       Date:  1990       Impact factor: 23.643

4.  Molecular cloning, sequence and functional expression of the cDNA for the human thyrotropin receptor.

Authors:  Y Nagayama; K D Kaufman; P Seto; B Rapoport
Journal:  Biochem Biophys Res Commun       Date:  1989-12-29       Impact factor: 3.575

5.  Autoregulation of the thyroid. Response to iodide excess and depletion.

Authors:  S H Ingbar
Journal:  Mayo Clin Proc       Date:  1972-11       Impact factor: 7.616

6.  Extracellular domain chimeras of the TSH and LH/CG receptors reveal the mid-region (amino acids 171-260) to play a vital role in high affinity TSH binding.

Authors:  Y Nagayama; D Russo; G D Chazenbalk; H L Wadsworth; B Rapoport
Journal:  Biochem Biophys Res Commun       Date:  1990-12-31       Impact factor: 3.575

7.  A functional site on the human TSH receptor: a potential therapeutic target in Graves' disease.

Authors:  Alan P Johnstone; Jeremy C Cridland; Clive R Da Costa; Stephen S Nussey; Philip S Shepherd
Journal:  Clin Endocrinol (Oxf)       Date:  2003-10       Impact factor: 3.478

8.  Glycoprotein hormone receptors: determinants in leucine-rich repeats responsible for ligand specificity.

Authors:  Guillaume Smits; Mercedes Campillo; Cédric Govaerts; Véronique Janssens; Christine Richter; Gilbert Vassart; Leonardo Pardo; Sabine Costagliola
Journal:  EMBO J       Date:  2003-06-02       Impact factor: 11.598

9.  Molecular cloning, sequencing and functional expression of porcine thyrotropin (TSH) receptor cDNA1).

Authors:  Makoto Igarashi; Atsuo Nagata
Journal:  Clin Chem Lab Med       Date:  2003-06       Impact factor: 3.694

10.  The effect of thyrotropin-receptor blocking antibodies on stimulating autoantibodies from patients with Graves' disease.

Authors:  Cornelia Lenzner; Nils G Morgenthaler
Journal:  Thyroid       Date:  2003-12       Impact factor: 6.568

View more
  13 in total

1.  The Synthesis and Evaluation of Dihydroquinazolin-4-ones and Quinazolin-4-ones as Thyroid Stimulating Hormone Receptor Agonists.

Authors:  Erika E Englund; Susanne Neumann; Elena Eliseeva; Joshua G McCoy; Steven Titus; Wei Zheng; Noel Southall; Paul Shin; William Leister; Craig J Thomas; James Inglese; Christopher P Austin; Marvin C Gershengorn; Wenwei Huang
Journal:  Medchemcomm       Date:  2011-10       Impact factor: 3.597

2.  Insight into thyroid-stimulating autoantibody interaction with the thyrotropin receptor N-terminus based on mutagenesis and re-evaluation of ambiguity in this region of the receptor crystal structure.

Authors:  Sepehr Hamidi; Chun-Rong Chen; Sandra M McLachlan; Basil Rapoport
Journal:  Thyroid       Date:  2011-08-11       Impact factor: 6.568

3.  Structure of a Thyrotropin Receptor Monoclonal Antibody Variable Region Provides Insight into Potential Mechanisms for its Inverse Agonist Activity.

Authors:  Chun-Rong Chen; Sandra M McLachlan; Paul A Hubbard; Randall McNally; Ramachandran Murali; Basil Rapoport
Journal:  Thyroid       Date:  2018-06-29       Impact factor: 6.568

4.  A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.

Authors:  Susanne Neumann; Wenwei Huang; Elena Eliseeva; Steve Titus; Craig J Thomas; Marvin C Gershengorn
Journal:  Endocrinology       Date:  2010-04-28       Impact factor: 4.736

5.  Thyrotropin (TSH) receptor residue E251 in the extracellular leucine-rich repeat domain is critical for linking TSH binding to receptor activation.

Authors:  Chun-Rong Chen; Sandra M McLachlan; Basil Rapoport
Journal:  Endocrinology       Date:  2010-02-24       Impact factor: 4.736

6.  Deleting the Redundant TSH Receptor C-Peptide Region Permits Generation of the Conformationally Intact Extracellular Domain by Insect Cells.

Authors:  Chun-Rong Chen; Larry M Salazar; Sandra M McLachlan; Basil Rapoport
Journal:  Endocrinology       Date:  2015-04-10       Impact factor: 4.736

7.  Human TSH receptor ligands as pharmacological probes with potential clinical application.

Authors:  Susanne Neumann; Bruce M Raaka; Marvin C Gershengorn
Journal:  Expert Rev Endocrinol Metab       Date:  2009-11-01

8.  A monoclonal antibody with thyrotropin (TSH) receptor inverse agonist and TSH antagonist activities binds to the receptor hinge region as well as to the leucine-rich domain.

Authors:  Chun-Rong Chen; Sandra M McLachlan; Basil Rapoport
Journal:  Endocrinology       Date:  2009-03-19       Impact factor: 4.736

9.  Vitamin D deficiency modulates Graves' hyperthyroidism induced in BALB/c mice by thyrotropin receptor immunization.

Authors:  Alexander Misharin; Martin Hewison; Chun-Rong Chen; Venu Lagishetty; Holly A Aliesky; Yumiko Mizutori; Basil Rapoport; Sandra M McLachlan
Journal:  Endocrinology       Date:  2008-10-16       Impact factor: 4.736

10.  Evidence that shed thyrotropin receptor A subunits drive affinity maturation of autoantibodies causing Graves' disease.

Authors:  Yumiko Mizutori; Chun-Rong Chen; Francesco Latrofa; Sandra M McLachlan; Basil Rapoport
Journal:  J Clin Endocrinol Metab       Date:  2008-12-09       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.